#1: HIV Cure Research Receives Financial Leg-Up from Gilead Sciences
According to a press release issued by the biopharmaceutical giant, a second round of recipients will receive financial support towards their research on a cure for HIV. A total of 5 HIV cure research initiatives will receive $7.5 million as recipients of Gilead’s HIV cure grants program.
The following individuals and their organizations and corresponding projects will receive grants to help fund their activities:
- Alexander Marson, MD, PhD, An Integrated CRISPR Platform to Discover Regulators of HIV Latency in Primary Human T Cells, University of California, San Francisco School of Medicine, Microbiology and Immunology, Chan Zuckerberg Biohub
- Monsef Benkirane, PhD, Paving the Way Towards Elimination of HIV Persistent CD4T Cell In Vivo, Institute of Human Genetics, French National Center for Scientific Research (CNRS) and University of Montpellier
- Abraham L. Brass, MD, PhD, A CRISPR/Cas9 Screen to Discover HIV-1 Latency Factors, University of Massachusetts Medical School
- Jeffrey D. Lifson, MD, TLR Ligand Augmented, Tissue Homing AIDS Virus-Specific Adoptive Cell Therapy to Target Viral Reservoirs, Frederick National Laboratory for Cancer Research, AIDS and Cancer Virus Program
- Joseph G. Sodroski, MD, Unlocking HIV-1 Env to Deplete Viral Reservoirs, Dana-Farber Cancer Institute
Read more about the grants, here
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.